GOTHENBURG, Sweden, Feb. 1, 2019 /PRNewswire/ -- Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL), today announced that all senior executives and employees participated in Isofol's share warrant program "2018" (series 2018/2022 and series 2018/2023). A total of 1,260,139...
from PR Newswire: https://prn.to/2HS7d4C
No comments:
Post a Comment